NCT01323010 Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing Episodes Status COMPLETED Phase NA
NCT01319656 Integration of Chronic Disease Rehabilitation Services Into Primary Care Status COMPLETED Phase NA
NCT01318980 A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A Status COMPLETED Phase PHASE1
NCT01316380 Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma Status COMPLETED Phase PHASE3
NCT01316315 Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma Status COMPLETED Phase PHASE1/PHASE2
NCT01313585 Device Mixing in Asthma, a General Practice Research Database Study Status COMPLETED Phase N/A
NCT01312961 Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma Status COMPLETED Phase PHASE2
NCT01312805 Using Computers to Assist in the Treatment of Asthma in a Pediatric Setting Status COMPLETED Phase NA
NCT01311661 A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma Status COMPLETED Phase PHASE2
NCT01310322 A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways Status COMPLETED Phase PHASE1
NCT01304901 Effect of Addition of Single Dose of Oral Montelukast to Standard Treatment in Acute Asthma in Preschool Children. Status COMPLETED Phase PHASE4
NCT01304628 Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma Status WITHDRAWN Phase PHASE2
NCT01302587 A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) Status COMPLETED Phase N/A
NCT01299558 Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01299467 A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge Status WITHDRAWN Phase PHASE1